Autopsy report · NCT06795373

Ritlecitinib (PF-06651600) in Participants With Chronic Spontaneous Urticaria

“Sponsor terminated study”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Ahuva D Cices

Sponsor type

University, hospital or other

Conditions

Chronic Spontaneous Urticaria; CSU

Interventions

Ritlecitinib

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Visual Function Tests in Age-related Macular Degeneration
  “Study terminated by Sponsor” (97% match in meaning)
• Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Liver Transplant Patients
  “Study terminated by the Sponsor” (96% match in meaning)
• Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
  “Study terminated at Sponsor's request.” (94% match in meaning)
• Prospective Case-Series of Ligasure Advance Pistol Grip and LigaSure Blunt Tip
  “The Sponsor terminated the study.” (92% match in meaning)
• Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation
  “Study termination by the Sponsor” (92% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.